Ricardo C. Rodriguez - 26 Aug 2024 Form 4 Insider Report for ASPEN AEROGELS INC (ASPN)

Role
CFO & Treasurer
Signature
/s/ Virginia H. Johnson, Attorney-in-Fact
Issuer symbol
ASPN
Transactions as of
26 Aug 2024
Net transactions value
-$806,094
Form type
4
Filing time
28 Aug 2024, 14:59:40 UTC
Previous filing
11 Mar 2024
Next filing
25 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASPN Common Stock Options Exercise $172,293 +25,300 +91% $6.81 53,255 26 Aug 2024 Direct F1
transaction ASPN Common Stock Sale $728,602 -24,198 -45% $30.11 29,057 26 Aug 2024 Direct F1, F2
transaction ASPN Common Stock Sale $33,776 -1,102 -3.8% $30.65 27,955 26 Aug 2024 Direct F1, F3
transaction ASPN Common Stock Sale $212,939 -7,065 -25% $30.14 20,890 26 Aug 2024 Direct F1, F4
transaction ASPN Common Stock Sale $3,070 -100 -0.48% $30.70 20,790 26 Aug 2024 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASPN Stock Option (Right to Buy) Options Exercise $0 -25,300 -33% $0.000000 50,679 26 Aug 2024 Common Stock 25,300 $6.81 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person on May 16, 2024.
F2 These transactions were executed in multiple trades at prices ranging from $29.55 to $30.50. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F3 These transactions were executed in multiple trades at prices ranging from $30.55 to $30.71. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F4 These transactions were executed in multiple trades at prices ranging from $29.68 to $30.59. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F5 Represents 20,790 Restricted Stock Units.
F6 The options are currently vested with respect to 25,326 shares. The remaining options vest in two installments as follows: 25,327 shares on March 8, 2025 and 25,326 shares on March 8, 2026.